These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner. Esfandiari A; Hawthorne TA; Nakjang S; Lunec J Mol Cancer Ther; 2016 Mar; 15(3):379-91. PubMed ID: 26832796 [TBL] [Abstract][Full Text] [Related]
23. c-JUN prevents methylation of p16(INK4a) (and Cdk6): the villain turned bodyguard. Kollmann K; Heller G; Sexl V Oncotarget; 2011 May; 2(5):422-7. PubMed ID: 21789792 [TBL] [Abstract][Full Text] [Related]
24. Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression. Buss H; Handschick K; Jurrmann N; Pekkonen P; Beuerlein K; Müller H; Wait R; Saklatvala J; Ojala PM; Schmitz ML; Naumann M; Kracht M PLoS One; 2012; 7(12):e51847. PubMed ID: 23300567 [TBL] [Abstract][Full Text] [Related]
25. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Kollmann K; Heller G; Schneckenleithner C; Warsch W; Scheicher R; Ott RG; Schäfer M; Fajmann S; Schlederer M; Schiefer AI; Reichart U; Mayerhofer M; Hoeller C; Zöchbauer-Müller S; Kerjaschki D; Bock C; Kenner L; Hoefler G; Freissmuth M; Green AR; Moriggl R; Busslinger M; Malumbres M; Sexl V Cancer Cell; 2013 Aug; 24(2):167-81. PubMed ID: 23948297 [TBL] [Abstract][Full Text] [Related]
26. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Böhlig L; Friedrich M; Engeland K Nucleic Acids Res; 2011 Jan; 39(2):440-53. PubMed ID: 20833636 [TBL] [Abstract][Full Text] [Related]
28. Differential regulation of cutaneous oncoprotein HPVE6 by wtp53, mutant p53R248W and ΔNp63α is HPV type dependent. Fei JW; de Villiers EM PLoS One; 2012; 7(4):e35540. PubMed ID: 22530045 [TBL] [Abstract][Full Text] [Related]
29. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma. Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099 [TBL] [Abstract][Full Text] [Related]
30. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion. Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170 [TBL] [Abstract][Full Text] [Related]
31. Chemical transformation of mouse liver cells results in altered cyclin D-CDK protein complexes. Gonzales AJ; Goldsworthy TL; Fox TR Carcinogenesis; 1998 Jun; 19(6):1093-102. PubMed ID: 9667749 [TBL] [Abstract][Full Text] [Related]
32. P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. Chen L; Zhang R; Li P; Liu Y; Qin K; Fa ZQ; Liu YJ; Ke YQ; Jiang XD Neurosci Lett; 2013 Feb; 534():327-32. PubMed ID: 23220650 [TBL] [Abstract][Full Text] [Related]
33. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p. Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519 [TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257 [TBL] [Abstract][Full Text] [Related]
35. Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer. Qian X; Durkin ME; Wang D; Tripathi BK; Olson L; Yang XY; Vass WC; Popescu NC; Lowy DR Cancer Res; 2012 Nov; 72(22):5900-11. PubMed ID: 23010077 [TBL] [Abstract][Full Text] [Related]
36. An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia. Lopez S; Voisset E; Tisserand JC; Mosca C; Prebet T; Santamaria D; Dubreuil P; De Sepulveda P Oncotarget; 2016 Aug; 7(32):51163-51173. PubMed ID: 27323399 [TBL] [Abstract][Full Text] [Related]
37. CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle. Fan Y; Li H; Liang X; Xiang Z Oncotarget; 2017 Mar; 8(12):19934-19946. PubMed ID: 28193906 [TBL] [Abstract][Full Text] [Related]
38. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. Hu MG; Deshpande A; Enos M; Mao D; Hinds EA; Hu GF; Chang R; Guo Z; Dose M; Mao C; Tsichlis PN; Gounari F; Hinds PW Cancer Res; 2009 Feb; 69(3):810-8. PubMed ID: 19155308 [TBL] [Abstract][Full Text] [Related]
39. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. Hüllein J; Słabicki M; Rosolowski M; Jethwa A; Habringer S; Tomska K; Kurilov R; Lu J; Scheinost S; Wagener R; Huang Z; Lukas M; Yavorska O; Helfrich H; Scholtysik R; Bonneau K; Tedesco D; Küppers R; Klapper W; Pott C; Stilgenbauer S; Burkhardt B; Löffler M; Trümper LH; Hummel M; Brors B; Zapatka M; Siebert R; Kreuz M; Keller U; Huber W; Zenz T Cancer Res; 2019 Jun; 79(12):3125-3138. PubMed ID: 31000522 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth. Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]